AlphaMol Presents First-in-Class Oral MRGPRX2 Modulator for Chronic Spontaneous Urticaria at EADV Congress 2026
Postive progress in the First-in-Class drug discovery
READ MORENEWS & INSIGHTS
Follow our progress across science, programs and partnerships.
Company updates, research milestones and perspectives from AlphaMol.
04 / 06
Industry Information
More stories
AlphMol obtained IND approval from both Chinese CDE and American FDA
We are very pleased to announce that AlphMol obtained IND approval from both Chinese CDE and American FDA for the leading auto immune pipeline.
READ MORE
AlphaMol discovered potential less-side effect painkiller
Recently, Professor Shuguang Yuan's team published a research paper titled
READ MORE
The co-founders of AlphaMol are in the ranking list of "Top 2% Scientists in the world"
The co-founders of AlphaMol, both Dr. Horst Vogel and Dr. Shugung Yuan are ranked as the 'Top 2% scientists' in the world
READ MORE